远大医药（中国）有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
229
NMPA:229
Drug Approvals
Pasireotide Diaspartate Injection
- Product Name
- 门冬氨酸帕瑞肽注射液
- Approval Number
- 国药准字H20254400
- Approval Date
- May 27, 2025
NMPA
Phenylephrine Hydrochloride Injection
- Product Name
- 盐酸去氧肾上腺素注射液
- Approval Number
- 国药准字H20253388
- Approval Date
- Feb 20, 2025
NMPA
Vigabatrin Powder for Oral Solution
- Product Name
- 氨己烯酸口服溶液用散
- Approval Number
- 国药准字H20249622
- Approval Date
- Dec 1, 2024
NMPA
Polyvinyl Alcohol Eye Drops
- Product Name
- 聚乙烯醇滴眼液
- Approval Number
- 国药准字H20244999
- Approval Date
- Sep 26, 2024
NMPA
Eltrombopag Olamine Tablets
- Product Name
- 艾曲泊帕乙醇胺片
- Approval Number
- 国药准字H20244389
- Approval Date
- Jul 9, 2024
NMPA
Metaraminol Bitartrate Injection
- Product Name
- 重酒石酸间羟胺注射液
- Approval Number
- 国药准字H20244128
- Approval Date
- Jun 25, 2024
NMPA
Hydroxychloroquine Sulfate Tablets
- Product Name
- 硫酸羟氯喹片
- Approval Number
- 国药准字H20243521
- Approval Date
- Apr 17, 2024
NMPA
Clemastine Fumarate Injection
- Product Name
- 富马酸氯马斯汀注射液
- Approval Number
- 国药准字H20140076
- Approval Date
- Mar 20, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 23
- Next
Clinical Trials
No trials found
News
No news found